Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.381
Peer-review started: December 11, 2023
First decision: January 4, 2024
Revised: January 18, 2024
Accepted: February 27, 2024
Article in press: February 27, 2024
Published online: March 24, 2024
Processing time: 102 Days and 0.4 Hours
Primary biliary tract tumors are malignancies that originate in the liver, bile ducts, or gallbladder. These tumors often present with jaundice of unknown etiology, leading to delayed diagnosis and advanced disease. Currently, several palliative treatment options are available for primary biliary tract tumors. They include percutaneous transhepatic biliary drainage (PTBD), biliary stenting, and surgical interventions such as biliary diversion. Systemic therapy is also commonly used for the palliative treatment of primary biliary tract tumors. It involves the administration of chemotherapy drugs, such as gemcitabine and cisplatin, which have shown promising results in improving overall survival in patients with advanced biliary tract tumors. PTBD is another palliative treatment option for patients with unresectable or inoperable malignant biliary obstruction. Biliary stenting can also be used as a palliative treatment option to alleviate symptoms in patients with unresectable or inoperable malignant biliary obstruction. Surgical interventions, such as biliary diversion, have traditionally been used as palliative options for primary biliary tract tumors. However, biliary diversion only provides temporary relief and does not remove the tumor. Primary biliary tract tumors often present in advanced stages, making palliative treatment the primary option for improving the quality of life of patients.
Core Tip: Nowadays, we still see a high incidence of primary biliary tract tumors arriving at emergency departments with a clinical picture of jaundice of unknown etiology. Unfortunately, when jaundice is diagnosed, most patients already show signs of advanced disease. It is up to the attending physician to offer the best alternatives for palliative treatment for a better quality of life of patients. The aim of this study is to evaluate the interventional palliative treatment options currently used to clinically improve symptoms and their results and related complications.